Huibin Lu
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 3
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Tracheal and airway disorders 9
-
- Esophageal and GI Pathology 6
- Head and Neck Surgical Oncology 2
-
- Cancer Mechanisms and Therapy 3
-
- Airway Management and Intubation Techniques 3
-
- RNA modifications and cancer 3
- Partner nations
- ChinaUnited States
In The Last Decade
Huibin Lu
24 papers receiving 562 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 196
- Hepatology 55
- Biochemistry 40
- Molecular Medicine 28
- Pharmacology 40
Countries citing papers authored by Huibin Lu
This map shows the geographic impact of Huibin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibin Lu more than expected).
Fields of papers citing papers by Huibin Lu
This network shows the impact of papers produced by Huibin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibin Lu. The network helps show where Huibin Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huibin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 43 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 8 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 3 | |
| 14 | 2017 | 131 | |
| 15 | 2016 | 14 | |
| 16 | 2016 | 61 | |
| 17 | 2016 | 29 | |
| 18 | 2016 | 82 | |
| 19 | [The application of Y-shaped self-expandable covered metal stents in the thoracostomach-airway fistula: a single center, 11 years experience]. | 2015 | 1 |
| 20 | 2013 | 22 |
About Huibin Lu
Huibin Lu is a scholar working on Hepatology, Anesthesiology and Pain Medicine and Applied Microbiology and Biotechnology, having authored 26 papers that have together received 573 indexed citations. Recurring topics across this work include Tracheal and airway disorders (9 papers), Esophageal and GI Pathology (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Mechanisms and Therapy (3 papers), Airway Management and Intubation Techniques (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers) and Head and Neck Surgical Oncology (2 papers). The work is most often cited by research in Cancer Research (196 citations), Hepatology (55 citations) and Biochemistry (40 citations). Huibin Lu has collaborated with scholars based in China and United States. Frequent co-authors include Kewei Ren, Xinwei Han, Jianzhuang Ren, Zong‐Ming Li, Xinwei Han, Zhanguo Sun, Gang Wu, Zongming Li, Wenzhe Zhang and Gang Wu. Their work appears in journals such as Translational Oncology, Cell Death Discovery, Medicine, Frontiers in Cell and Developmental Biology and Respiration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.